Zobrazeno 1 - 10 of 78 pro vyhledávání: '"Kei Matsueda"'
1
Akademický článek
Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study
Autor: Kei Matsueda, Shin Fukudo, Masayuki Ogishima, Yuki Naito, Soichiro Nakamura
Publikováno v: BioPsychoSocial Medicine, Vol 18, Iss 1, Pp 1-13 (2024)
Abstract Background In Europe, an herbal medicine containing peppermint oil is widely used in patients with irritable bowel syndrome (IBS). In Japan, however, no clinical evidence for peppermint oil in IBS has been established, and it has not been ap
Externí odkaz: https://doaj.org/article/e24e46f6cac943169e1433e6fed1ca06
Zobrazit plný text záznamu
2
Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
Autor: Shin Fukudo, Toshikatsu Okumura, Masahiko Inamori, Yusuke Okuyama, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Akiko Shiotani, Yuji Naito, Yoshiko Fujikawa, Ryota Hokari, Tastuhiro Masaoka, Kazuma Fujimoto, Hiroshi Kaneko, Akira Torii, Kei Matsueda, Hiroto Miwa, Nobuyuki Enomoto, Tooru Shimosegawa, Kazuhiko Koike
Publikováno v: Journal of Gastroenterology
Managing irritable bowel syndrome (IBS) has attracted international attention because single-agent therapy rarely relieves bothersome symptoms for all patients. The Japanese Society of Gastroenterology (JSGE) published the first edition of evidence-b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e94dc4f6bbbb14a9d8593471ca6a74ae
https://pubmed.ncbi.nlm.nih.gov/33538894
Zobrazit plný text záznamu
3
Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea
Autor: Yoshihiro Nakashima, Hiraku Akiho, Shin Fukudo, Kei Matsueda, Akito Nishida, Motoko Ida
Publikováno v: Biopsychosocial Medicine
Background Global assessment allows patients to assess improvement in multiple irritable bowel syndrome (IBS) symptoms. However, it was deemed important to assess “clinically meaningful improvements, focusing on the patient’s chief complaint and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6e222bdc3c19039cbeba85b5708c596
https://pubmed.ncbi.nlm.nih.gov/28331539
Zobrazit plný text záznamu
4
Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo-controlled phase II study
Autor: Kei Matsueda, Ken Haruma, Yoshihiro Nakashima, H Hayase, Motoko Ida, Shin Fukudo, Hiraku Akiho, Michio Hongo
Publikováno v: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 29(6)
BACKGROUND Previous studies showed that 5 μg of ramosetron, a serotonin (5-hydroxytryptamine: 5-HT)-3 receptor antagonist, is only effective in male patients with irritable bowel syndrome (IBS) with diarrhea (IBS-D). We hypothesized that either dose
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d11050994a10587acca5eff53267421d
https://pubmed.ncbi.nlm.nih.gov/28205278
Zobrazit plný text záznamu
5
Large-scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega-Study (JMMS)
Autor: Chikashi Shibata, Tetsuya Mine, Nobuyoshi Hanyu, Kei Matsueda, Koji Nakada, Michio Hongo, Motoyasu Kusano, Shigeru Harasawa, Iwao Sasaki
Publikováno v: Journal of Gastroenterology and Hepatology. 27:62-68
Background and Aim: Functional dyspepsia (FD) is a common condition seen in primary gastroenterology practice. The present study was conducted to compare the clinical effectiveness of mosapride and teprenone in patients with FD. Methods: Prospective
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4ce84b7c329af14e27a2614bff4a2233
https://doi.org/10.1111/j.1440-1746.2011.06949.x
Zobrazit plný text záznamu
6
High Prevalence of Irritable Bowel Syndrome in Medical Outpatients in Japan
Autor: Tetsuo Arakawa, Ken Haruma, Shigeru Kitamori, Masae Shinozaki, Takeshi Azuma, Michio Hongo, Shin Fukudo, Daisuke Sasaki, Masanori Handa, Tetsuya Mine, Soichiro Miura, Akira Torii, Mikihiko Fukunaga, Tooru Shimosegawa, Kei Matsueda, Hiroto Miwa, Hiroshi Kaneko, Shigeru Harasawa, Takeshi Miwa
Publikováno v: Journal of Clinical Gastroenterology. 42:1010-1016
Background and Goals: The prevalence of irritable bowel syndrome (IBS) among Japanese patients who visit hospitals departments of internal medicine is thought to be high. However, no clear statistical evidence has been provided to support such a clai
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616839e2c905523d5f466f8fc5e4fd0d
https://doi.org/10.1097/mcg.0b013e318150d006
Zobrazit plný text záznamu
7
Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon
Autor: Hirotsugu Uehara, Shigeru Yamato, Takazumi Kimura, Kei Matsueda, Tsuyoshi Ishida, Hajime Ariga, Tomofumi Amano, Hisao Tajiri, Akira Torii
Publikováno v: American Journal of Physiology-Gastrointestinal and Liver Physiology. 293:G903-G910
Corticotropin-releasing factor (CRF) and urocortin I (UcnI) have been shown to accelerate colonic transit after central nervous system (CNS) or peripheral administration, but the mechanism of their peripheral effect on colonic motor function has not
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac5d5d7e1ec8d1249df14f9c45bce7aa
https://doi.org/10.1152/ajpgi.00066.2007
Zobrazit plný text záznamu
8
Design of Treatment Trials for Functional Gastrointestinal Disorders
Autor: E Jan, Irvine, William E, Whitehead, William D, Chey, Kei, Matsueda, Michael, Shaw, Nicholas J, Talley, Sander J O, Veldhuyzen van Zanten
Publikováno v: Gastroenterology. 130:1538-1551
This document addresses the design of trials to assess the efficacy of new treatments for functional gastrointestinal disorders (FGID), emphasizing trials in irritable bowel syndrome and dyspepsia, because most research has been undertaken in these c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b519af9692daa997a3b8eb1bb93d1a24
https://doi.org/10.1053/j.gastro.2005.11.058
Zobrazit plný text záznamu
10
Effect of acotiamide on gastric emptying in healthy adult humans
Autor: Yoshihisa Urita, Hiroaki Zai, Youichi Saito, Motoyasu Kusano, Kei Matsueda, Hiroki Kato
Publikováno v: European journal of clinical investigation. 44(12)
Background Acotiamide is a first-in-class drug that is used to treat functional dyspepsia (FD). It is considered that acotiamide acts as an antagonist on muscarinic autoreceptors in the enteric nervous system and inhibits acetylcholinesterase activit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4d3391f44e78e869b85c0c03a0ecc3a
https://pubmed.ncbi.nlm.nih.gov/25370953
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje